[1]
Cruz NetoJ.J., MacêdoN. de A.R., SilvaS.F. da, OliveiraA.P.C., LucenaG. dos S.J., NunesL.F., SantanaV.L.A., RamosK.S., OliveiraL.L. de and CastroR.C. 2024. Use of SGLT2 inhibitors in the treatment of compensated heart failure in diabetic patients. Electronic Journal Collection Health. 24, 6 (Jun. 2024), e16262. DOI:https://doi.org/10.25248/reas.e16262.2024.